Health Resources Sample Clauses

Health Resources. Inc. and Vendor acknowledge that certain confidential and proprietary information may be disclosed by one of them to the other in the course of this Agreement. For purposes of this Agreement, the term "Confidential Information" includes the following: (a) All information regarding the patient, Health Resources, Inc.'s Customer, any patient medical data and/or status, or provider information; and (b) any other information identified as confidential in writing by the disclosing party prior to disclosure. Notwithstanding the confidentiality requirements of this Agreement, the foregoing shall not prevent Health Resources, Inc. from retaining information, including any and all information and data pertaining to any patient which comes to Health Resources, Inc. or to which Health Resources, Inc. is given access during this Agreement.
AutoNDA by SimpleDocs
Health Resources. Access to Blue Advantage online health resources.
Health Resources. While they are few in number and some were unfamiliar to the FGDPs, there are a handful of health resources available to help farm workers in the southwest Georgia community deal with the diet-related health conditions facing them. Not surprisingly, there were some commonalities in the discussions about barriers to accessing healthy food and barriers to accessing these healthcare and health resources. The local migrant health clinic, for example, offers a holistic approach to health that encompasses clinical care and health education. KI-1 highlighted the clinic’s nutrition education course; however, members of only one of the three FGDs were familiar with this program. Meanwhile, KI-3 mentioned the role of the Red Cross, Mental Health Services, and other organizations in referring people to the food bank. He estimated that most farm workers who use the food bank are referred by Mental Health Services. During the FGDs, participants were familiar with the clinic’s basic services but (in general) did not express knowledge of extra programs or outside organizations. The FGDPs and the key informants alike acknowledged that, while there are a handful of health resources available to them, farm workers are often not informed about their existence and encounter many barriers when trying to access these resources in southwest Georgia. Several women said that their families frequently did not have enough money to buy everything they needed/wanted; childcare and medical attention were mentioned as priorities that must often be foregone. It is possible that there is a sort of “feedback” cycle wherein some women do not go to the clinic often due to financial constraints, and therefore, those same women do not have the opportunity to learn about the clinic’s full range of services. Discussion and conclusion Summary of study Study design and goals. The current study used a cross-sectional mixed methods design to understand the associations between food insecurity, diet diversity, and health outcomes, including anemia, elevated/high blood glucose, hypertension, and overweight/obesity, among migrant farm workers in southwest Georgia and the ways in which these farm workers perceive their own health and access to healthy food. A high prevalence of both food insecurity (66.1%) and low/medium dietary diversity (61.3%) was observed. Additionally, in the surveyed subset, 22.4% were hypertensive, 49.4% were anemic, 33.5% had high blood glucose and additional 41.1% had elevated ...

Related to Health Resources

  • Company Resources (a) Company will be solely responsible, at Company's expense, for procuring, maintaining, and supporting all third-party software other than Third Party Products and all workstations, personal computers, printers, controllers or other hardware or peripheral equipment at Company's sites ("Company System") required for Company to operate the Licensed System in accordance with the Documentation and specifications provided by BNYM from time to time. BNYM will provide Company with specifications for Company System, including any requirements relating to the connection and operation of the Company System with the Licensed System and Third Party Products. Company shall conform its operating system environment to the operating system requirements provided by BNYM for the Licensed System. Company will support and maintain the Company System as necessary to ensure its operation does not impact the Licensed System adversely or otherwise in a manner not contemplated by the Documentation.

  • Resources Contractor is responsible for providing any and all facilities, materials and resources (including personnel, equipment and software) necessary and appropriate for performance of the Services and to meet Contractor's obligations under this Agreement.

  • REGULATORY ADMINISTRATION SERVICES BNY Mellon shall provide the following regulatory administration services for each Fund and Series:  Assist the Fund in responding to SEC examination requests by providing requested documents in the possession of BNY Mellon that are on the SEC examination request list and by making employees responsible for providing services available to regulatory authorities having jurisdiction over the performance of such services as may be required or reasonably requested by such regulatory authorities;  Assist with and/or coordinate such other filings, notices and regulatory matters and other due diligence requests or requests for proposal on such terms and conditions as BNY Mellon and the applicable Fund on behalf of itself and its Series may mutually agree upon in writing from time to time; and

  • Transportation Management Tenant shall fully comply with all present or future programs intended to manage parking, transportation or traffic in and around the Building, and in connection therewith, Tenant shall take responsible action for the transportation planning and management of all employees located at the Premises by working directly with Landlord, any governmental transportation management organization or any other transportation-related committees or entities.

  • Customer Relations A. Actively promote DCP Holding Company in all Marketing, Sales, Public Relations, and Community activity.

  • Information Systems The Official Agency in conjunction with the Authority will meet the relevant requirements of Articles 131 to 136 of Regulation (EU) 2017/625 and Implementing Regulation (EU) 2019/1715 as appropriate to the Official Agency. The Official Agency shall record appropriate data in the Official Agency Premises Inspection database (OAPI), which will be further developed over the life of the contract. Data should be entered into the database on an ongoing basis but shall be entered within one month of the activity taking place, unless otherwise agreed with the Authority.

  • Financial Resources The Adviser has the financial resources available to it necessary for the performance of its services and obligations contemplated in the Pricing Disclosure Package, the Prospectus, and under this Agreement, the Investment Management Agreement and the Administration Agreement.

  • Program Management 1.1.01 Implement and operate an Immunization Program as a Responsible Entity

  • Environmental, Health and Safety i. Environment, Health and Safety Performance. Seller acknowledges and accepts full and sole responsibility to maintain an environment, health and safety management system ("EMS") appropriate for its business throughout the performance of this Contract. Buyer expects that Seller’s EMS shall promote health and safety, environmental stewardship, and pollution prevention by appropriate source reduction strategies. Seller shall convey the requirement of this clause to its suppliers. Seller shall not deliver goods that contain asbestos mineral fibers.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, Registration Statement, the Pricing Disclosure Package or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with applicable laws, rules, regulations and policies of the Food and Drug Administration of the U.S. Department of Health and Human Services (the “FDA”) or any committee thereof or of any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are materially inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Pricing Disclosure Package or the Prospectus; for such studies that have been or are being conducted, the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by foreign government or drug or medical device regulatory agencies, or foreign health care facility Institutional Review Boards; and no investigational new drug application filed by or on behalf of the Company or any of its subsidiaries with the FDA has been terminated or suspended by the FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or ongoing studies conducted or proposed to be conducted by or on behalf of the Company or any of its subsidiaries.

Time is Money Join Law Insider Premium to draft better contracts faster.